Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF-Reference-Cited by-同舟云学术

Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF

Published:2005 Issue:6 Volume:115 Page:951-959
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ahmad Murrium,Rees Robert C.,McArdle Stephanie E.,Li Geng,Mian Shahid,Entwisle Claire,Loudon Peter,Ali Selman A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference48 articles.

1. The role of CD4+ T cell responses in antitumor immunity

2. CD4 T Cells and Their Role in Antitumor Immune Responses

3. Why are dendritic cells central to cancer immunotherapy?

4. Cancer vaccines

5. Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model;PROTEOMICS - Clinical Applications;2010-03-24

2. Cancer vaccines: Uses of HLA transgenic mice compared to genetically modified mice;Frontiers in Bioscience;2009

3. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte–macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus;Cancer Gene Therapy;2007-08-10

4. The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines;Cancer Immunology, Immunotherapy;2006-03-23

5. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells;International Journal of Cancer;2006